Adverse Drug Reaction Alert - gene
ADReCS ID | ADR Term | ADReCS ID | ADR Term |
---|---|---|---|
01.01.01 | Coagulation factor deficiencies | 14.06.02 | Hyperglycaemic conditions NEC |
01.01.02 | Coagulopathies | 14.06.03 | Hypoglycaemic conditions NEC |
01.01.03 | Bleeding tendencies | 14.07.01 | Diabetic complications ophthalmic |
01.01.04 | Purpuras (excl thrombocytopenic) | 14.07.02 | Diabetic complications renal |
01.02.01 | Leukocytoses NEC | 14.07.03 | Diabetic complications NEC |
01.02.02 | Leukopenias NEC | 14.07.04 | Diabetic complications neurological |
01.02.03 | Neutropenias | 14.07.06 | Diabetic complications dermal |
01.02.04 | Eosinophilic disorders | 14.08.01 | Elevated cholesterol |
01.02.05 | White blood cell abnormal findings NEC | 14.08.02 | Elevated triglycerides |
01.03.01 | Anaemia deficiencies | 14.08.03 | Hyperlipidaemias NEC |
01.03.02 | Anaemias NEC | 14.08.04 | Lipid metabolism and deposit disorders NEC |
01.03.03 | Marrow depression and hypoplastic anaemias | 14.09.01 | Disorders of purine metabolism |
01.04.01 | Haemoglobinopathies NEC | 14.10.01 | Protein metabolism disorders NEC |
01.04.02 | Sickle cell trait and disorders | 14.11.01 | Metabolic disorders NEC |
01.04.03 | Thalassaemic disorders | 14.11.02 | Cell metabolism disorders NEC |
01.05.01 | Haematological disorders | 14.12.01 | Vitamin deficiencies NEC |
01.06.01 | Anaemias haemolytic immune | 14.12.02 | Water soluble vitamin deficiencies |
01.06.02 | Anaemias haemolytic mechanical factor | 14.12.03 | Fat soluble vitamin deficiencies and disorders |
01.06.03 | Anaemias haemolytic NEC | 14.12.04 | Hypervitaminoses NEC |
01.06.04 | Haemolyses NEC | 14.13.02 | Iron deficiencies |
01.07.01 | Polycythaemia (excl rubra vera) | 14.13.03 | Iron excess |
01.07.02 | Red blood cell abnormal findings NEC | 14.13.04 | Mineral related disorders NEC |
01.08.01 | Thrombocytopenias | 14.14.01 | Inborn errors of porphyrin metabolism |
01.08.02 | Thrombocytoses | 14.14.02 | Lysosomal storage disorders |
01.08.03 | Platelet disorders NEC | 14.14.04 | Inborn errors of amino acid metabolism |
01.09.01 | Lymphatic system disorders NEC | 15.01.01 | Arthropathies NEC |
01.09.02 | Spleen disorders | 15.01.02 | Joint related signs and symptoms |
01.09.03 | Liver and spleen enlargement | 15.01.03 | Rheumatoid arthropathies |
01.10.01 | Leukaemias acute lymphocytic | 15.01.04 | Osteoarthropathies |
01.10.02 | Leukaemias acute NEC | 15.01.06 | Crystal arthropathic disorders |
01.10.03 | Leukaemias NEC | 15.01.07 | Joint dislocations |
01.10.04 | Myelodysplastic syndromes | 15.01.08 | Joint related disorders NEC |
01.10.05 | Leukaemias acute myeloid | 15.01.09 | Spondyloarthropathies |
01.10.06 | Leukaemias chronic lymphocytic | 15.02.01 | Bone related signs and symptoms |
01.10.08 | Leukaemias myeloid NEC | 15.02.02 | Epiphyseal disorders |
01.10.09 | Leukaemias lymphocytic NEC | 15.02.03 | Metabolic bone disorders |
01.11.03 | Mycoses fungoides | 15.02.04 | Bone disorders NEC |
01.12.01 | Lymphomas unspecified NEC | 15.02.05 | Bone and joint infections (excl arthritis) |
01.13.01 | Haematologic neoplasms NEC | 15.03.01 | Musculoskeletal and connective tissue signs and symptoms NEC |
01.13.02 | Lymphoproliferative disorders NEC (excl leukaemias and lymphomas) | 15.03.02 | Soft tissue disorders NEC |
01.13.03 | Myeloproliferative disorders (excl leukaemias) | 15.03.03 | Musculoskeletal and connective tissue infections and inflammations NEC |
01.14.01 | Plasma cell neoplasms NEC | 15.03.04 | Musculoskeletal and connective tissue pain and discomfort |
01.14.02 | Plasma cell myelomas | 15.04.01 | Bursal disorders |
01.15.02 | Diffuse large B-cell lymphomas | 15.04.02 | Synovial disorders |
01.15.04 | Burkitt's lymphomas | 15.05.01 | Muscle infections and inflammations |
01.15.05 | Mantle cell lymphomas | 15.05.02 | Muscle pains |
01.16.01 | Hodgkin's disease NEC | 15.05.03 | Muscle related signs and symptoms NEC |
01.17.01 | Non-Hodgkin's lymphomas NEC | 15.05.04 | Muscle tone abnormalities |
02.01.01 | Cardiac disorders NEC | 15.05.05 | Myopathies |
02.01.02 | Cardiac signs and symptoms NEC | 15.05.06 | Muscle weakness conditions |
02.01.03 | Dyspnoeas | 15.05.07 | Muscle injuries |
02.02.01 | Coronary artery disorders NEC | 15.05.08 | Myasthenia gravis and related conditions |
02.02.02 | Ischaemic coronary artery disorders | 15.06.01 | Connective tissue disorders NEC |
02.03.01 | Cardiac conduction disorders | 15.06.02 | Lupus erythematosus (incl subtypes) |
02.03.02 | Rate and rhythm disorders NEC | 15.07.01 | Tendon disorders |
02.03.03 | Supraventricular arrhythmias | 15.07.02 | Ligament disorders |
02.03.04 | Ventricular arrhythmias and cardiac arrest | 15.07.03 | Cartilage disorders |
02.04.01 | Cardiomyopathies | 15.08.02 | Fractures NEC |
02.04.02 | Myocardial disorders NEC | 15.08.03 | Limb fractures |
02.04.03 | Noninfectious myocarditis | 15.08.05 | Spinal column fractures |
02.05.01 | Heart failures NEC | 15.08.06 | Pelvic fractures |
02.05.02 | Left ventricular failures | 15.08.07 | Thoracic cage fractures non-spinal |
02.05.03 | Right ventricular failures | 15.09.01 | Benign musculoskeletal and connective tissue neoplasms |
02.05.04 | Heart failure signs and symptoms | 15.09.02 | Musculoskeletal and connective tissue neoplasms NEC |
02.06.01 | Pericardial disorders NEC | 15.09.03 | Malignant musculoskeletal and connective tissue neoplasms |
02.06.02 | Noninfectious pericarditis | 15.10.01 | Intervertebral disc disorders NEC |
02.07.01 | Mitral valvular disorders | 15.11.01 | Non-site specific bone disorders congenital |
02.07.02 | Cardiac valve disorders NEC | 15.11.02 | Musculoskeletal and connective tissue disorders of skull congenital |
02.07.04 | Pulmonary valvular disorders | 15.11.04 | Musculoskeletal and connective tissue disorders of spine congenital |
02.09.01 | Endocarditis NEC | 15.11.05 | Musculoskeletal and connective tissue disorders of face, neck and jaw congenital |
02.09.02 | Endocardial disorders NEC | 15.11.06 | Musculoskeletal disorders congenital NEC |
02.09.03 | Endocardial bacterial infections | 15.11.07 | Musculoskeletal and connective tissue disorders of limbs congenital |
03.01.01 | Ocular disorders congenital NEC | 15.11.08 | Connective tissue disorders congenital |
03.01.03 | Retinal disorders congenital | 16.01.01 | Leukaemias acute lymphocytic |
03.02.01 | Congenital disorders NEC | 16.01.02 | Leukaemias acute NEC |
03.02.02 | Chemically-induced congenital syndromes | 16.01.03 | Leukaemias NEC |
03.03.01 | Male reproductive tract disorders congenital | 16.01.04 | Myelodysplastic syndromes |
03.03.02 | Reproductive tract disorders congenital NEC | 16.01.05 | Leukaemias acute myeloid |
03.03.03 | Breast disorders congenital | 16.01.06 | Leukaemias chronic lymphocytic |
03.04.02 | Palate disorders congenital | 16.01.08 | Leukaemias myeloid NEC |
03.04.03 | Oral cavity disorders congenital NEC | 16.01.09 | Leukaemias lymphocytic NEC |
03.04.04 | Intestinal disorders congenital | 16.02.01 | Cardiovascular neoplasms benign |
03.04.05 | Gastric disorders congenital | 16.02.02 | Neoplasms benign site unspecified NEC |
03.04.07 | Gastrointestinal tract disorders congenital NEC | 16.03.01 | Skin melanomas (excl ocular) |
03.05.01 | Skin and subcutaneous tissue disorders congenital NEC | 16.03.02 | Skin neoplasms malignant and unspecified (excl melanoma) |
03.06.01 | Renal disorders congenital | 16.04.02 | Uterine neoplasms benign |
03.06.02 | Renal and urinary tract disorders congenital NEC | 16.04.03 | Ovarian neoplasms benign |
03.06.03 | Bladder disorders congenital | 16.05.02 | Lower gastrointestinal neoplasms benign |
03.07.02 | Cardiac septal defects congenital | 16.05.03 | Upper gastrointestinal neoplasms benign |
03.07.03 | Vascular anomalies congenital NEC | 16.05.04 | Lip and oral cavity neoplasms benign |
03.07.05 | Cardiac valve disorders congenital | 16.06.01 | Hepatobiliary neoplasms benign |
03.07.07 | Cardiac disorders congenital NEC | 16.07.01 | Bile duct neoplasms malignant |
03.08.01 | Inborn errors of porphyrin metabolism | 16.07.02 | Hepatic neoplasms malignant |
03.08.02 | Lysosomal storage disorders | 16.07.03 | Hepatobiliary neoplasms malignancy unspecified |
03.08.04 | Inborn errors of amino acid metabolism | 16.07.05 | Gallbladder neoplasms malignant |
03.09.01 | Endocrine disorders congenital NEC | 16.08.01 | Bladder neoplasms malignant |
03.10.02 | Central nervous system disorders congenital NEC | 16.08.02 | Renal neoplasms malignant |
03.10.03 | Cerebral disorders congenital | 16.08.03 | Urinary tract neoplasms unspecified malignancy NEC |
03.11.01 | Non-site specific bone disorders congenital | 16.09.01 | Nervous system neoplasms benign NEC |
03.11.02 | Musculoskeletal and connective tissue disorders of skull congenital | 16.09.02 | Neuromas |
03.11.04 | Musculoskeletal and connective tissue disorders of spine congenital | 16.10.01 | Breast and nipple neoplasms malignant |
03.11.05 | Musculoskeletal and connective tissue disorders of face, neck and jaw congenital | 16.10.02 | Breast neoplasms unspecified malignancy |
03.11.06 | Musculoskeletal disorders congenital NEC | 16.11.01 | Cartilage neoplasms benign |
03.11.07 | Musculoskeletal and connective tissue disorders of limbs congenital | 16.12.01 | Cervix neoplasms malignant |
03.11.08 | Connective tissue disorders congenital | 16.12.02 | Endometrial neoplasms malignant |
03.12.01 | Autosomal chromosomal abnormalities | 16.12.04 | Ovarian neoplasms malignant (excl germ cell) |
03.12.02 | Chromosomal abnormalities NEC | 16.12.06 | Female reproductive neoplasms unspecified malignancy |
03.13.01 | External ear disorders congenital | 16.13.01 | Colorectal neoplasms malignant |
03.13.02 | Ear disorders congenital NEC | 16.13.03 | Gastric neoplasms malignant |
03.15.01 | Coagulation disorders congenital | 16.13.04 | Gastrointestinal neoplasms malignant NEC |
03.15.02 | Haematological disorders congenital NEC | 16.13.05 | Anal canal neoplasms malignant |
03.15.03 | Haemoglobinopathies congenital | 16.13.06 | Oesophageal neoplasms malignant |
03.17.01 | Immune system abnormalities congenital | 16.13.07 | Lip and oral cavity neoplasms malignant |
04.01.01 | External ear disorders NEC | 16.13.09 | Lip and oral cavity neoplasms malignancy unspecified |
04.01.02 | External ear infections and inflammations | 16.13.10 | Pancreatic neoplasms malignant (excl islet cell and carcinoid) |
04.02.01 | Hearing losses | 16.13.11 | Gastrointestinal neoplasms malignancy unspecified NEC |
04.02.02 | Hyperacusia | 16.14.01 | Breast and nipple neoplasms benign |
04.02.03 | Hearing disorders NEC | 16.16.01 | Neoplasms malignant site unspecified NEC |
04.03.01 | Ear disorders NEC | 16.16.02 | Neoplasms unspecified malignancy and site unspecified NEC |
04.04.01 | Inner ear signs and symptoms | 16.17.03 | Mycoses fungoides |
04.04.02 | Inner ear disorders NEC | 16.18.01 | Soft tissue neoplasms benign NEC |
04.04.03 | Inner ear infections and inflammations | 16.19.01 | Non-small cell neoplasms malignant of the respiratory tract cell type specified |
04.05.01 | Middle ear infections and inflammations | 16.19.02 | Respiratory tract and pleural neoplasms malignant cell type unspecified NEC |
04.05.02 | Eustachian tube disorders | 16.19.03 | Laryngeal neoplasms malignant |
04.05.03 | Middle ear disorders NEC | 16.19.04 | Respiratory tract and pleural neoplasms malignancy unspecified NEC |
04.05.04 | Tympanic membrane disorders (excl infections) | 16.19.05 | Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified |
04.06.01 | Congenital external ear disorders | 16.19.06 | Laryngeal neoplasms malignancy unspecified |
04.06.02 | Congenital ear disorders (excl external ear) | 16.19.08 | Respiratory tract small cell carcinomas |
05.01.01 | Adrenal cortical hyperfunctions | 16.20.01 | Lymphomas unspecified NEC |
05.01.02 | Adrenal cortical hypofunctions | 16.21.01 | Haematologic neoplasms NEC |
05.01.03 | Adrenal gland disorders NEC | 16.21.02 | Lymphoproliferative disorders NEC (excl leukaemias and lymphomas) |
05.01.04 | Adrenal neoplasms | 16.21.03 | Myeloproliferative disorders (excl leukaemias) |
05.02.01 | Thyroid disorders NEC | 16.22.01 | Metastases to unknown and unspecified sites |
05.02.02 | Thyroid hyperfunction disorders | 16.22.02 | Metastases to specified sites |
05.02.03 | Thyroid hypofunction disorders | 16.23.01 | Plasma cell neoplasms NEC |
05.02.04 | Acute and chronic thyroiditis | 16.23.02 | Plasma cell myelomas |
05.02.05 | Thyroid neoplasms | 16.24.01 | Endocrine neoplasms malignant and unspecified NEC |
05.03.01 | Anterior pituitary hyperfunction | 16.24.02 | Islet cell neoplasms and APUDoma NEC |
05.03.02 | Anterior pituitary hypofunction | 16.24.03 | Thyroid neoplasms malignant |
05.03.03 | Posterior pituitary disorders | 16.24.04 | Carcinoid tumours |
05.03.04 | Hypothalamic and pituitary disorders NEC | 16.24.05 | Multiple endocrine neoplasias |
05.04.01 | Hyperparathyroid disorders | 16.25.01 | Prostatic neoplasms malignant |
05.04.02 | Hypoparathyroid disorders | 16.25.02 | Reproductive neoplasms male unspecified malignancy |
05.04.03 | Parathyroid disorders NEC | 16.26.01 | Skin neoplasms benign |
05.05.01 | Female gonadal function disorders | 16.26.02 | Skin cysts and polyps |
05.05.02 | Male gonadal function disorders | 16.27.01 | Renal neoplasms benign |
05.05.03 | Endocrine abnormalities of puberty | 16.28.02 | Diffuse large B-cell lymphomas |
05.05.04 | Endocrine abnormalities of gonadal function NEC | 16.28.04 | Burkitt's lymphomas |
05.06.01 | Diabetes mellitus (incl subtypes) | 16.28.05 | Mantle cell lymphomas |
05.06.02 | Hyperglycaemic conditions NEC | 16.30.01 | Nervous system neoplasms unspecified malignancy NEC |
05.06.03 | Hypoglycaemic conditions NEC | 16.30.03 | Nervous system neoplasms malignant NEC |
05.07.01 | Diabetic complications ophthalmic | 16.30.04 | Central nervous system neoplasms malignant NEC |
05.07.02 | Diabetic complications renal | 16.31.01 | Hodgkin's disease NEC |
05.07.03 | Diabetic complications NEC | 16.32.01 | Paraneoplastic syndromes NEC |
05.07.04 | Diabetic complications neurological | 16.32.03 | Oncologic complications and emergencies |
05.07.06 | Diabetic complications dermal | 16.33.01 | Soft tissue sarcomas histology unspecified |
05.08.01 | Endocrine neoplasms NEC | 16.33.02 | Kaposi's sarcomas |
05.08.02 | Ectopic endocrine disorders | 16.34.01 | Ocular cysts and polyps |
05.08.03 | Multiple endocrine neoplasia syndromes | 16.35.01 | Non-Hodgkin's lymphomas NEC |
05.09.01 | Endocrine disorders NEC | 16.36.01 | Prostatic neoplasms benign |
06.01.01 | Ocular sensation disorders | 16.38.01 | Nasal and paranasal sinus neoplasms benign |
06.02.01 | Amblyopic vision impairment | 17.01.01 | Choreiform movements |
06.02.02 | Blindness (excl colour blindness) | 17.01.02 | Dyskinesias and movement disorders NEC |
06.02.03 | Partial vision loss | 17.01.03 | Dystonias |
06.02.04 | Refractive and accommodative disorders | 17.01.04 | Paralysis and paresis (excl cranial nerve) |
06.02.05 | Visual colour distortions | 17.01.05 | Parkinson's disease and parkinsonism |
06.02.06 | Visual disorders NEC | 17.01.06 | Tremor (excl congenital) |
06.02.07 | Visual field disorders | 17.02.01 | Abnormal reflexes |
06.02.08 | Visual pathway disorders | 17.02.02 | Coordination and balance disturbances |
06.02.09 | Colour blindness (incl acquired) | 17.02.03 | Cortical dysfunction NEC |
06.03.01 | Glaucomas (excl congenital) | 17.02.04 | Disturbances in consciousness NEC |
06.04.01 | Conjunctival infections, irritations and inflammations | 17.02.05 | Neurological signs and symptoms NEC |
06.04.02 | Corneal infections, oedemas and inflammations | 17.02.06 | Paraesthesias and dysaesthesias |
06.04.03 | Iris and uveal tract infections, irritations and inflammations | 17.02.07 | Sensory abnormalities NEC |
06.04.04 | Lid, lash and lacrimal infections, irritations and inflammations | 17.02.08 | Speech and language abnormalities |
06.04.05 | Ocular infections, inflammations and associated manifestations | 17.02.09 | Coma states |
06.04.06 | Retinal, choroid and vitreous infections and inflammations | 17.02.10 | Nervous system disorders NEC |
06.04.07 | Scleral infections, irritations and inflammations | 17.02.11 | Pupillary signs |
06.04.08 | Optic nerve infections and inflammations | 17.02.12 | Vertigos NEC |
06.05.01 | Eyelid movement disorders | 17.03.01 | Dementia (excl Alzheimer's type) |
06.05.02 | Ocular nerve and muscle disorders | 17.03.02 | Memory loss (excl dementia) |
06.05.03 | Pupil disorders | 17.03.03 | Mental impairment (excl dementia and memory loss) |
06.06.01 | Cataract conditions | 17.03.04 | Mental retardations |
06.06.02 | Conjunctival structural change, deposit and degeneration | 17.04.01 | Cranial nerve disorders NEC |
06.06.03 | Corneal structural change, deposit and degeneration | 17.04.02 | Eye movement disorders |
06.06.04 | Lid, lash and lacrimal structural disorders | 17.04.03 | Facial cranial nerve disorders |
06.06.05 | Lens structural change, deposit and degeneration (excl cataracts) | 17.04.04 | Olfactory nerve disorders |
06.06.06 | Iris and ciliary body structural change, deposit and degeneration | 17.04.05 | Optic nerve disorders NEC |
06.07.01 | Conjunctival and corneal bleeding and vascular disorders | 17.04.06 | Vagus nerve disorders |
06.07.02 | Ocular bleeding and vascular disorders NEC | 17.04.07 | Auditory nerve disorders |
06.07.04 | Anterior chamber bleeding and vascular disorders | 17.04.08 | Trigeminal disorders |
06.08.01 | Corneal disorders NEC | 17.04.09 | Hypoglossal nerve disorders |
06.08.02 | Lacrimation disorders | 17.05.01 | Autonomic nervous system disorders |
06.08.03 | Ocular disorders NEC | 17.05.02 | Muscle tone abnormal |
06.09.01 | Choroid and vitreous structural change, deposit and degeneration | 17.05.03 | Neuromuscular disorders NEC |
06.09.02 | Optic disc abnormalities NEC | 17.05.04 | Neuromuscular junction dysfunction |
06.09.03 | Retinal structural change, deposit and degeneration | 17.05.05 | Motor neurone diseases |
06.09.04 | Structural change, deposit and degeneration of eye NEC | 17.06.01 | Central nervous system inflammatory disorders NEC |
06.09.05 | Orbital structural change, deposit and degeneration | 17.06.02 | Myelitis (incl infective) |
06.09.06 | Scleral structural change, deposit and degeneration | 17.06.03 | Meningitis NEC |
06.10.01 | Retinal bleeding and vascular disorders (excl retinopathy) | 17.06.04 | Meningeal fungal infections |
06.10.02 | Retinopathies NEC | 17.06.05 | Encephalitis NEC |
06.10.03 | Choroid and vitreous haemorrhages and vascular disorders | 17.06.06 | Encephalitis of viral origin |
06.11.01 | Ocular injuries NEC | 17.06.07 | Central nervous system abscesses |
06.11.02 | Optic pathway injuries | 17.06.08 | Meningeal viral infections |
06.12.01 | Ocular cysts and polyps | 17.06.09 | Nervous system infections NEC |
06.13.02 | Congenital eye disorders NEC | 17.06.10 | Meningeal bacterial infections |
07.01.01 | Abdominal findings abnormal | 17.07.01 | Hydrocephalic conditions |
07.01.02 | Dyspeptic signs and symptoms | 17.07.02 | Increased intracranial pressure disorders |
07.01.03 | Faecal abnormalities NEC | 17.08.01 | Central nervous system haemorrhages and cerebrovascular accidents |
07.01.04 | Flatulence, bloating and distension | 17.08.02 | Central nervous system vascular disorders NEC |
07.01.05 | Gastrointestinal and abdominal pains (excl oral and throat) | 17.08.04 | Transient cerebrovascular events |
07.01.06 | Gastrointestinal signs and symptoms NEC | 17.08.05 | Traumatic central nervous system haemorrhages |
07.01.07 | Nausea and vomiting symptoms | 17.09.01 | Acute polyneuropathies |
07.02.01 | Diarrhoea (excl infective) | 17.09.02 | Mononeuropathies |
07.02.02 | Gastrointestinal atonic and hypomotility disorders NEC | 17.09.03 | Peripheral neuropathies NEC |
07.02.03 | Gastrointestinal dyskinetic disorders | 17.09.04 | Chronic polyneuropathies |
07.02.04 | Gastrointestinal spastic and hypermotility disorders | 17.10.01 | Spinal cord and nerve root disorders NEC |
07.02.05 | Non-mechanical ileus | 17.10.02 | Cervical spinal cord and nerve root disorders |
07.03.01 | Anal and rectal disorders NEC | 17.10.03 | Lumbar spinal cord and nerve root disorders |
07.03.02 | Anal and rectal pains | 17.10.04 | Spinal cord and nerve root disorders traumatic |
07.03.03 | Anal and rectal signs and symptoms | 17.11.01 | Structural brain disorders NEC |
07.04.02 | Duodenal ulcers and perforation | 17.12.01 | Generalised tonic-clonic seizures |
07.04.03 | Gastric ulcers and perforation | 17.12.03 | Seizures and seizure disorders NEC |
07.04.04 | Gastrointestinal ulcers and perforation, site unspecified | 17.12.04 | Absence seizures |
07.04.05 | Oesophageal ulcers and perforation | 17.13.01 | Encephalopathies toxic and metabolic |
07.04.06 | Intestinal ulcers and perforation NEC | 17.13.02 | Encephalopathies NEC |
07.04.07 | Peptic ulcers and perforation | 17.14.01 | Headaches NEC |
07.05.01 | Oral soft tissue disorders NEC | 17.14.02 | Migraine headaches |
07.05.02 | Oral soft tissue haemorrhages | 17.15.01 | Narcolepsy and hypersomnia |
07.05.03 | Oral soft tissue pain and paraesthesia | 17.15.02 | Abnormal sleep-related events |
07.05.04 | Oral soft tissue swelling and oedema | 17.15.03 | Disturbances in initiating and maintaining sleep |
07.05.05 | Oral soft tissue signs and symptoms | 17.15.04 | Sleep disturbances NEC |
07.05.06 | Stomatitis and ulceration | 17.15.05 | Sleep apnoeas |
07.05.07 | Oral soft tissue infections | 17.15.06 | Disturbances in sleep phase rhythm |
07.05.08 | Cleft lip and cleft palate disorders | 17.16.01 | Multiple sclerosis acute and progressive |
07.06.01 | Oral dryness and saliva altered | 17.16.02 | Demyelinating disorders NEC |
07.06.02 | Salivary gland disorders NEC | 17.17.01 | Neurologic visual problems NEC |
07.06.03 | Salivary gland enlargements | 17.17.02 | Ocular signs and symptoms NEC |
07.06.04 | Salivary gland infections and inflammations | 17.18.01 | Nervous system neoplasms benign NEC |
07.06.05 | Salivary gland stenosis and obstruction | 17.18.02 | Neuromas |
07.07.01 | Peritoneal and retroperitoneal disorders | 17.19.01 | Congenital and hereditary central nervous system disorders NEC |
07.07.02 | Peritoneal and retroperitoneal haemorrhages | 17.19.03 | Congenital and peripartum cerebral disorders |
07.07.03 | Peritoneal and retroperitoneal fibrosis and adhesions | 17.20.01 | Nervous system neoplasms unspecified malignancy NEC |
07.08.01 | Colitis (excl infective) | 17.20.03 | Nervous system neoplasms malignant NEC |
07.08.02 | Gastritis (excl infective) | 17.20.04 | Central nervous system neoplasms malignant NEC |
07.08.03 | Gastrointestinal inflammatory disorders NEC | 18.01.01 | Abortions not specified as induced or spontaneous |
07.08.04 | Rectal inflammations NEC | 18.01.02 | Stillbirth and foetal death |
07.08.05 | Oesophagitis (excl infective) | 18.01.03 | Abortion related conditions and complications |
07.09.01 | Dental and periodontal infections and inflammations | 18.01.04 | Abortions spontaneous |
07.09.02 | Dental surface disorders | 18.02.03 | Hypertension associated disorders of pregnancy |
07.09.03 | Gingival disorders NEC | 18.03.01 | Foetal growth complications |
07.09.04 | Gingival pains | 18.03.02 | Foetal complications NEC |
07.09.05 | Dental disorders NEC | 18.03.03 | Foetal conditions due to maternal conditions |
07.09.06 | Dental pain and sensation disorders | 18.04.01 | Newborn complications NEC |
07.09.07 | Gingival haemorrhages | 18.04.03 | Neonatal haematologic disorders (excl blood incompatibility) |
07.09.08 | Dental developmental disorders and anomalies | 18.04.04 | Neonatal neurological system disorders NEC |
07.09.09 | Tooth missing | 18.04.06 | Neonatal metabolic and endocrine disorders |
07.09.11 | Gingival discolourations | 18.04.08 | Neonatal hepatobiliary disorders |
07.09.12 | Dental pulp disorders | 18.04.09 | Neonatal respiratory disorders NEC |
07.10.01 | Diverticula | 18.04.11 | Neonatal gastrointestinal disorders |
07.10.02 | Diverticulum inflammations | 18.04.12 | Neonatal infections (excl congenital infections) |
07.11.01 | Gastrointestinal disorders NEC | 18.04.14 | Umbilical cord complications |
07.11.02 | Oesophageal disorders NEC | 18.05.01 | Amniotic fluid and cavity disorders of pregnancy NEC |
07.11.03 | Gastrointestinal mucosal dystrophies and secretion disorders | 18.05.02 | Placental abnormalities (excl neoplasms) |
07.11.04 | Congenital gastrointestinal malformations | 18.06.02 | Postpartum breast disorders |
07.11.05 | Gastrointestinal fistulae | 18.07.01 | Labour onset and length abnormalities |
07.12.01 | Gastric and oesophageal haemorrhages | 18.07.02 | Maternal complications of labour NEC |
07.12.02 | Non-site specific gastrointestinal haemorrhages | 18.07.03 | Failed labour |
07.12.03 | Intestinal haemorrhages | 18.08.01 | Unintended pregnancies |
07.13.01 | Gastrointestinal stenosis and obstruction NEC | 18.08.02 | Normal pregnancy, labour and delivery |
07.13.02 | Oesophageal stenosis and obstruction | 18.08.03 | Multiple pregnancies |
07.13.03 | Large intestinal stenosis and obstruction | 19.01.01 | Abnormal behaviour NEC |
07.13.04 | Gastric and pyloric stenosis and obstruction | 19.01.02 | Psychiatric symptoms NEC |
07.13.06 | Duodenal and small intestinal stenosis and obstruction | 19.02.01 | Disturbances in initiating and maintaining sleep |
07.14.01 | Tongue disorders | 19.02.02 | Narcolepsy and associated conditions |
07.14.02 | Tongue signs and symptoms | 19.02.03 | Parasomnias |
07.14.03 | Taste disorders | 19.02.04 | Sleep disorders NEC |
07.15.01 | Gastrointestinal necrosis and gangrene (excl gangrenous hernia) | 19.02.05 | Dyssomnias |
07.15.02 | Gastrointestinal vascular occlusion and infarction | 19.02.06 | Sleep phase rhythm disturbances |
07.15.03 | Haemorrhoids and gastrointestinal varices (excl oesophageal) | 19.03.01 | Psychotic disorder NEC |
07.15.05 | Oesophageal varices | 19.03.02 | Schizoaffective and schizophreniform disorders |
07.16.01 | Diaphragmatic hernias | 19.03.03 | Delusional disorders |
07.16.02 | Inguinal hernias | 19.03.04 | Schizophrenia NEC |
07.16.03 | Umbilical hernias | 19.04.01 | Affect alterations NEC |
07.16.06 | Abdominal hernias NEC | 19.04.02 | Emotional and mood disturbances NEC |
07.17.01 | Malabsorption syndromes | 19.04.03 | Fluctuating mood symptoms |
07.18.01 | Acute and chronic pancreatitis | 19.04.04 | Mood disorders NEC |
07.18.02 | Pancreatic disorders NEC | 19.05.01 | Behaviour and socialisation disturbances |
07.19.01 | Intestinal infections | 19.05.02 | Personality disorders NEC |
07.19.02 | Gastrointestinal infections, site unspecified | 19.05.03 | Personality disorders with dramatic behaviour (Cluster B) |
07.19.03 | Gastric and gastroenteric infections | 19.06.01 | Anxiety disorders NEC |
07.19.04 | Anal, rectal, perianal and perirectal infections | 19.06.02 | Anxiety symptoms |
07.19.05 | Peritoneal infections | 19.06.03 | Fear symptoms and phobic disorders (incl social phobia) |
07.19.06 | Oesophageal infections | 19.06.04 | Panic attacks and disorders |
07.20.01 | Benign neoplasms gastrointestinal (excl oral cavity) | 19.06.05 | Obsessive-compulsive disorders and symptoms |
07.20.02 | Benign oral cavity neoplasms | 19.06.06 | Stress disorders |
07.21.01 | Malignant intestinal neoplasms | 19.07.01 | Mental disorders NEC |
07.21.02 | Gastric neoplasms malignant | 19.07.02 | Substance-related disorders |
07.21.03 | Malignant miscellaneous gastrointestinal neoplasms | 19.07.03 | Mental disorders due to a general medical condition NEC |
07.21.04 | Gastrointestinal neoplasms NEC | 19.07.04 | Psychiatric elimination disorders |
07.21.05 | Malignant anorectal neoplasms | 19.07.05 | Infancy, childhood and adolescence psychiatric disorders NEC |
07.21.06 | Oesophageal neoplasms malignant | 19.08.01 | Orgasmic disorders and disturbances |
07.21.07 | Malignant oral cavity neoplasms | 19.08.03 | Sexual desire disorders |
07.21.08 | Oral cavity neoplasms NEC | 19.08.04 | Sexual arousal disorders |
07.21.09 | Pancreatic neoplasms | 19.08.05 | Sexual dysfunction NEC |
08.01.01 | Asthenic conditions | 19.09.01 | Eating disorders NEC |
08.01.02 | Gait disturbances | 19.10.01 | Delusional symptoms |
08.01.03 | General signs and symptoms NEC | 19.10.02 | Perception disturbances |
08.01.04 | Hernias NEC | 19.10.03 | Thinking disturbances |
08.01.05 | Inflammations | 19.11.01 | Decreased physical activity levels |
08.01.06 | Mucosal findings abnormal | 19.11.02 | Increased physical activity levels |
08.01.07 | Oedema NEC | 19.11.03 | Stereotypies and automatisms |
08.01.08 | Pain and discomfort NEC | 19.11.04 | Tic disorders |
08.01.09 | Feelings and sensations NEC | 19.12.01 | Suicidal and self-injurious behaviour |
08.02.01 | Application and instillation site reactions | 19.13.01 | Confusion and disorientation |
08.02.02 | Implant and catheter site reactions | 19.13.02 | Deliria |
08.02.03 | Injection site reactions | 19.14.01 | Dissociative states |
08.02.04 | Administration site reactions NEC | 19.15.01 | Depressive disorders |
08.02.05 | Infusion site reactions | 19.15.02 | Mood alterations with depressive symptoms |
08.03.01 | Fibrosis NEC | 19.16.01 | Bipolar disorders |
08.03.02 | Healing abnormal NEC | 19.16.02 | Mood alterations with manic symptoms |
08.03.03 | Necrosis NEC | 19.17.01 | Somatoform disorders |
08.03.04 | Trophic disorders | 19.18.01 | Impulse control disorders |
08.03.05 | Mass conditions NEC | 19.19.01 | Communications disorders |
08.03.06 | Ulcers NEC | 19.19.02 | Speech and language usage disturbances |
08.04.01 | Death and sudden death | 19.19.03 | Speech articulation and rhythm disturbances |
08.05.01 | Body temperature altered | 19.20.01 | Amnestic symptoms |
08.05.02 | Febrile disorders | 19.20.02 | Dementia NEC |
08.06.01 | Therapeutic and nontherapeutic responses | 19.21.01 | Specific cognitive ability disturbances |
08.06.02 | Withdrawal and rebound effects | 19.21.02 | Cognitive and attention disorders and disturbances NEC |
08.07.01 | Complications associated with device NEC | 19.21.03 | Mental retardations |
08.07.02 | Respiratory complications associated with device | 19.22.01 | Developmental motor skills disorders |
08.08.01 | Device physical property and chemical issues | 20.01.01 | Renal failure complications |
08.08.02 | Device malfunction events NEC | 20.01.02 | Renal disorders NEC |
08.09.01 | Product physical issues | 20.01.03 | Renal failure and impairment |
09.01.01 | Cholestasis and jaundice | 20.01.04 | Renal neoplasms |
09.01.02 | Hepatic enzymes and function abnormalities | 20.01.05 | Renal obstructive disorders |
09.01.03 | Hepatic failure and associated disorders | 20.01.07 | Renal vascular and ischaemic conditions |
09.01.04 | Hepatic fibrosis and cirrhosis | 20.01.08 | Renal hypertension and related conditions |
09.01.05 | Hepatobiliary signs and symptoms | 20.01.09 | Renal infections and inflammations (excl nephritis) |
09.01.06 | Hepatic vascular disorders | 20.02.01 | Urinary abnormalities |
09.01.07 | Hepatocellular damage and hepatitis NEC | 20.02.02 | Bladder and urethral symptoms |
09.01.08 | Hepatic and hepatobiliary disorders NEC | 20.02.03 | Urinary tract signs and symptoms NEC |
09.01.09 | Hepatic viral infections | 20.03.01 | Bladder disorders NEC |
09.01.10 | Hepatic metabolic disorders | 20.03.02 | Bladder infections and inflammations |
09.01.11 | Hepatic infections (excl viral) | 20.03.03 | Myoneurogenic bladder disorders |
09.02.01 | Bile duct infections and inflammations | 20.03.04 | Bladder neoplasms |
09.02.02 | Obstructive bile duct disorders (excl neoplasms) | 20.03.05 | Bladder reflux conditions |
09.02.03 | Structural and other bile duct disorders | 20.04.01 | Renal lithiasis |
09.03.01 | Cholecystitis and cholelithiasis | 20.04.02 | Urinary tract lithiasis (excl renal) |
09.03.02 | Gallbladder disorders NEC | 20.05.01 | Glomerulonephritis and nephrotic syndrome |
09.04.01 | Hepatobiliary neoplasms benign | 20.05.02 | Nephritis NEC |
09.04.02 | Malignant hepatobiliary neoplasms | 20.05.03 | Nephropathies and tubular disorders NEC |
09.04.03 | Hepatobiliary neoplasms NEC | 20.06.01 | Ureteric disorders NEC |
10.01.01 | Allergies to foods, food additives, drugs and other chemicals | 20.07.01 | Urethral disorders NEC |
10.01.02 | Anaphylactic responses | 20.07.02 | Urethral infections and inflammations |
10.01.03 | Allergic conditions NEC | 20.07.03 | Structural and obstructive urethral disorders (excl congenital) |
10.01.04 | Atopic disorders | 20.08.01 | Genital and urinary tract disorders NEC |
10.01.05 | Angioedemas | 20.08.02 | Genitourinary tract infections and inflammations NEC |
10.01.06 | Urticarias | 20.08.03 | Congenital genitourinary tract anomalies NEC |
10.02.01 | Immune and associated conditions NEC | 21.01.01 | Menstruation and uterine bleeding NEC |
10.02.02 | Vasculitides | 21.01.02 | Menstruation with decreased bleeding |
10.02.03 | Transplant rejections | 21.01.03 | Menstruation with increased bleeding |
10.02.04 | Blood isoimmune reactions | 21.02.01 | Menopausal effects on the genitourinary tract |
10.02.05 | Amyloidoses | 21.02.02 | Menopausal effects NEC |
10.02.06 | Acute and chronic sarcoidosis | 21.03.01 | Erection and ejaculation conditions and disorders |
10.03.01 | Primary immunodeficiency syndromes | 21.03.02 | Sexual function and fertility disorders NEC |
10.03.02 | Immunodeficiency disorders NEC | 21.03.03 | Spermatogenesis and semen disorders |
10.03.03 | Acquired immunodeficiency syndromes | 21.04.01 | Prostatic signs, symptoms and disorders NEC |
10.04.01 | Blood autoimmune disorders | 21.04.02 | Prostatic neoplasms and hypertrophy |
10.04.02 | Skin autoimmune disorders NEC | 21.05.01 | Benign and malignant breast neoplasms |
10.04.03 | Lupus erythematosus and associated conditions | 21.05.02 | Lactation disorders |
10.04.04 | Autoimmune disorders NEC | 21.05.03 | Breast infections and inflammations |
10.04.05 | Muscular autoimmune disorders | 21.05.04 | Breast disorders NEC |
10.04.06 | Rheumatoid arthritis and associated conditions | 21.05.05 | Breast signs and symptoms |
10.04.07 | Scleroderma and associated disorders | 21.06.01 | Cervix disorders NEC |
10.04.08 | Endocrine autoimmune disorders | 21.06.02 | Cervix neoplasms |
10.04.09 | Hepatic autoimmune disorders | 21.07.01 | Uterine disorders NEC |
10.04.10 | Nervous system autoimmune disorders | 21.07.02 | Uterine neoplasms |
11.01.01 | Bone and joint infections | 21.07.03 | Uterine tone disorders |
11.01.02 | Breast infections | 21.07.04 | Pelvis and broad ligament disorders NEC |
11.01.03 | Central nervous system and spinal infections | 21.07.05 | Pelvic prolapse conditions |
11.01.04 | Dental and oral soft tissue infections | 21.08.01 | Vulvovaginal disorders NEC |
11.01.05 | Ear infections | 21.08.02 | Vulvovaginal signs and symptoms |
11.01.06 | Eye and eyelid infections | 21.09.01 | Prostate and seminal vesicles infections and inflammations |
11.01.07 | Abdominal and gastrointestinal infections | 21.09.02 | Testicular and epididymal infections and inflammations |
11.01.08 | Infections NEC | 21.09.03 | Penile and scrotal infections and inflammations |
11.01.09 | Lower respiratory tract and lung infections | 21.10.01 | Reproductive tract signs and symptoms NEC |
11.01.10 | Female reproductive tract infections | 21.10.03 | Reproductive tract infections and inflammations NEC |
11.01.11 | Sepsis, bacteraemia, viraemia and fungaemia NEC | 21.10.05 | Reproductive tract disorders NEC (excl neoplasms) |
11.01.12 | Skin structures and soft tissue infections | 21.11.01 | Ovarian and fallopian tube cysts and neoplasms |
11.01.13 | Upper respiratory tract infections | 21.11.02 | Ovarian and fallopian tube disorders NEC |
11.01.14 | Urinary tract infections | 21.12.01 | Penile disorders NEC (excl erection and ejaculation) |
11.01.15 | Vascular infections | 21.12.02 | Scrotal disorders NEC |
11.01.16 | Cardiac infections | 21.13.01 | Testicular and epididymal disorders NEC |
11.01.17 | Muscle and soft tissue infections | 21.14.01 | Uterine infections and inflammations (excl cervix) |
11.01.18 | Hepatobiliary and spleen infections | 21.14.02 | Vaginal and vulval infections and inflammations |
11.01.19 | Male reproductive tract infections | 21.14.03 | Fallopian tube and ovary infections and inflammations |
11.02.01 | Bacterial infections NEC | 21.14.04 | Pelvic and site unspecified infections and inflammations |
11.02.02 | Clostridia infections | 21.14.05 | Cervix infections and inflammations |
11.02.03 | Klebsiella infections | 21.15.01 | Congenital male reproductive tract disorders |
11.02.04 | Nocardia infections | 21.15.02 | Congenital breast and reproductive tract disorders NEC |
11.02.05 | Staphylococcal infections | 22.01.01 | Lower respiratory tract inflammatory and immunologic conditions |
11.02.06 | Streptococcal infections | 22.01.02 | Parenchymal lung disorders NEC |
11.02.08 | Enterococcal infections | 22.01.03 | Pulmonary oedemas |
11.02.09 | Enterobacter infections | 22.01.05 | Occupational parenchymal lung disorders |
11.02.10 | Escherichia infections | 22.02.01 | Breathing abnormalities |
11.02.11 | Listeria infections | 22.02.02 | Conditions associated with abnormal gas exchange |
11.02.12 | Pseudomonal infections | 22.02.03 | Coughing and associated symptoms |
11.02.13 | Treponema infections | 22.02.04 | Lower respiratory tract signs and symptoms |
11.02.14 | Neisseria infections | 22.02.05 | Upper respiratory tract signs and symptoms |
11.02.17 | Borrelial infections | 22.02.06 | Respiratory failures (excl neonatal) |
11.02.18 | Helicobacter infections | 22.02.07 | Respiratory tract disorders NEC |
11.03.01 | Aspergillus infections | 22.02.08 | Respiratory signs and symptoms NEC |
11.03.02 | Blastomyces infections | 22.03.01 | Bronchospasm and obstruction |
11.03.03 | Candida infections | 22.03.02 | Bronchial conditions NEC |
11.03.04 | Cryptococcal infections | 22.04.01 | Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms) |
11.03.05 | Fungal infections NEC | 22.04.02 | Laryngeal spasm, oedema and obstruction |
11.03.06 | Histoplasma infections | 22.04.03 | Nasal disorders NEC |
11.03.07 | Pneumocystis infections | 22.04.04 | Nasal congestion and inflammations |
11.03.08 | Tinea infections | 22.04.05 | Pharyngeal disorders (excl infections and neoplasms) |
11.04.01 | Tuberculous infections | 22.04.06 | Paranasal sinus disorders (excl infections and neoplasms) |
11.04.02 | Atypical mycobacterial infections | 22.04.07 | Tracheal disorders (excl infections and neoplasms) |
11.05.01 | Cytomegaloviral infections | 22.05.01 | Pleural infections and inflammations |
11.05.02 | Herpes viral infections | 22.05.02 | Pneumothorax and pleural effusions NEC |
11.05.03 | Influenza viral infections | 22.05.03 | Pleural conditions NEC |
11.05.04 | Viral infections NEC | 22.05.04 | Pleural neoplasms |
11.05.05 | Polyomavirus infections | 22.06.01 | Pulmonary hypertensions |
11.05.06 | Hepatitis viral infections | 22.06.02 | Pulmonary thrombotic and embolic conditions |
11.05.07 | Papilloma viral infections | 22.07.01 | Lower respiratory tract infections NEC |
11.05.09 | Adenoviral infections | 22.07.02 | Viral upper respiratory tract infections |
11.05.10 | Epstein-Barr viral infections | 22.07.03 | Upper respiratory tract infections NEC |
11.05.11 | Parainfluenzae viral infections | 22.07.04 | Bacterial upper respiratory tract infections |
11.05.12 | Molluscum contagiosum viral infections | 22.07.05 | Viral lower respiratory tract infections |
11.05.13 | Respiratory syncytial viral infections | 22.07.06 | Bacterial lower respiratory tract infections |
11.05.14 | Enteroviral infections NEC | 22.07.07 | Respiratory tract infections NEC |
11.05.16 | Poliomyelitis viral infections | 22.07.08 | Fungal lower respiratory tract infections |
11.05.17 | Retroviral infections | 22.08.01 | Lower respiratory tract neoplasms |
11.06.01 | Toxoplasma infections | 22.08.02 | Upper respiratory tract neoplasms |
11.06.04 | Plasmodia infections | 22.09.01 | Thoracic musculoskeletal disorders |
11.07.01 | Inflammatory disorders following infection | 22.09.02 | Diaphragmatic disorders |
11.08.02 | Cestode infections | 22.09.03 | Mediastinal disorders |
11.10.01 | Mycoplasma infections | 22.11.01 | Newborn respiratory disorders NEC |
12.01.02 | Abdominal injuries NEC | 23.01.01 | Hyperkeratoses |
12.01.03 | Chest and lung injuries NEC | 23.01.02 | Ichthyoses |
12.01.04 | Eye injuries NEC | 23.01.03 | Skin dystrophies |
12.01.05 | Renal and urinary tract injuries NEC | 23.01.04 | Skin hyperplasias and hypertrophies |
12.01.06 | Skin injuries NEC | 23.01.05 | Skin hypoplasias and atrophies |
12.01.07 | Muscle, tendon and ligament injuries | 23.01.06 | Skin preneoplastic conditions NEC |
12.01.08 | Non-site specific injuries NEC | 23.02.01 | Acnes |
12.01.09 | Site specific injuries NEC | 23.02.02 | Alopecias |
12.01.10 | Cerebral injuries NEC | 23.02.03 | Apocrine and eccrine gland disorders |
12.01.11 | Cardiovascular injuries | 23.02.04 | Hypertrichoses |
12.01.12 | Nerve injuries NEC | 23.02.05 | Nail and nail bed conditions (excl infections and infestations) |
12.01.13 | Spinal cord injuries NEC | 23.02.06 | Pilar disorders NEC |
12.01.14 | Ear injuries NEC | 23.02.07 | Sebaceous gland disorders |
12.01.16 | Cranial nerve injuries | 23.02.08 | Rosaceas |
12.02.01 | Cardiac and vascular procedural complications | 23.03.01 | Bullous conditions |
12.02.02 | Eye and ear procedural complications | 23.03.02 | Connective tissue disorders |
12.02.03 | Gastrointestinal and hepatobiliary procedural complications | 23.03.03 | Dermal and epidermal conditions NEC |
12.02.04 | Neurological and psychiatric procedural complications | 23.03.04 | Dermatitis and eczema |
12.02.05 | Non-site specific procedural complications | 23.03.05 | Dermatitis ascribed to specific agent |
12.02.06 | Skin procedural complications | 23.03.06 | Erythemas |
12.02.07 | Respiratory tract and thoracic cavity procedural complications | 23.03.07 | Exfoliative conditions |
12.02.08 | Transfusion related complications | 23.03.08 | Papulosquamous conditions |
12.02.09 | Transplantation complications | 23.03.09 | Photosensitivity and photodermatosis conditions |
12.02.10 | Urinary tract procedural complications | 23.03.10 | Pustular conditions |
12.02.11 | Vaccination related complications | 23.03.11 | Skin injuries and mechanical dermatoses |
12.02.13 | Musculoskeletal procedural complications | 23.03.12 | Pruritus NEC |
12.03.01 | Poisoning and toxicity | 23.03.13 | Rashes, eruptions and exanthems NEC |
12.03.02 | Chemical injuries | 23.03.14 | Psoriatic conditions |
12.03.03 | Foetal and neonatal conditions associated with product exposure | 23.03.15 | Granulomatous and deep cutaneous inflammatory conditions |
12.04.01 | Limb fractures and dislocations | 23.03.16 | Scaly conditions |
12.04.02 | Fractures and dislocations NEC | 23.04.01 | Angioedemas |
12.04.03 | Bone and joint injuries NEC | 23.04.02 | Urticarias |
12.04.04 | Spinal fractures and dislocations | 23.05.01 | Hyperpigmentation disorders |
12.04.06 | Pelvic fractures and dislocations | 23.05.02 | Hypopigmentation disorders |
12.04.07 | Thoracic cage fractures and dislocations | 23.05.03 | Pigmentation changes NEC |
12.05.01 | Heat injuries (excl thermal burns) | 23.06.01 | Purpura and related conditions |
12.05.02 | Radiation injuries | 23.06.02 | Skin vasculitides |
12.05.03 | Conditions caused by cold | 23.06.03 | Telangiectasia and related conditions |
12.05.04 | Thermal burns | 23.06.04 | Skin vascular conditions NEC |
12.06.01 | Medication errors NEC | 23.06.05 | Skin vasomotor conditions |
12.07.01 | Application and instillation site reactions | 23.06.06 | Skin ischaemic conditions |
12.07.02 | Implant and catheter site reactions | 23.06.07 | Skin haemorrhages |
12.07.03 | Injection site reactions | 23.07.01 | Lipodystrophies |
12.07.04 | Administration site reactions NEC | 23.07.02 | Panniculitides |
12.07.05 | Infusion site reactions | 23.07.03 | Skin and subcutaneous tissue ulcerations |
12.08.01 | Overdoses NEC | 23.07.04 | Skin and subcutaneous conditions NEC |
13.01.01 | Blood grouping and cross-matching analyses | 23.07.05 | Skin and subcutaneous malformations and anomalies NEC |
13.01.02 | Coagulation and bleeding analyses | 23.08.01 | Skin melanomas (excl ocular) |
13.01.03 | Haematological analyses NEC | 23.08.02 | Skin neoplasms malignant and unspecified (excl melanoma) |
13.01.04 | Platelet analyses | 23.09.01 | Skin and subcutaneous tissue bacterial infections |
13.01.05 | Red blood cell analyses | 23.09.02 | Skin and subcutaneous tissue fungal infections |
13.01.06 | White blood cell analyses | 23.09.03 | Skin and subcutaneous tissue viral infections |
13.02.01 | Blood gas and acid base analyses | 23.09.04 | Skin and subcutaneous tissue infections NEC |
13.02.02 | Carbohydrate tolerance analyses (incl diabetes) | 23.10.01 | Skin neoplasms benign |
13.02.03 | Haem metabolism analyses | 23.10.02 | Skin cysts and polyps |
13.02.04 | Metabolism tests NEC | 24.01.01 | Non-site specific embolism and thrombosis |
13.02.05 | Vitamin analyses | 24.01.02 | Peripheral embolism and thrombosis |
13.03.01 | Liver function analyses | 24.01.03 | Hepatic and portal embolism and thrombosis |
13.04.01 | Skeletal and cardiac muscle analyses | 24.01.04 | Cerebrovascular embolism and thrombosis |
13.04.02 | Tissue enzyme analyses NEC | 24.01.05 | Site specific embolism and thrombosis NEC |
13.05.01 | Digestive enzymes | 24.01.06 | Pulmonary embolism and thrombosis |
13.05.02 | Faecal analyses NEC | 24.01.07 | Retinal embolism and thrombosis |
13.05.03 | Gastrointestinal histopathology procedures | 24.01.08 | Gastrointestinal embolism and thrombosis |
13.05.04 | Gastrointestinal function diagnostic procedures | 24.02.01 | Aneurysms and dissections non-site specific |
13.06.01 | Autoimmunity analyses | 24.02.02 | Aneurysms and dissections site specific NEC |
13.06.03 | Immunology analyses NEC | 24.02.03 | Aortic aneurysms and dissections |
13.06.04 | Immunology skin tests NEC | 24.03.01 | Peripheral vascular disorders NEC |
13.06.05 | Immunoglobulin analyses | 24.03.02 | Non-site specific vascular disorders NEC |
13.07.02 | Cerebrospinal fluid tests (excl microbiology) | 24.03.03 | Vascular malformations and acquired anomalies |
13.07.03 | Neurologic diagnostic procedures | 24.03.04 | Site specific vascular disorders NEC |
13.07.04 | Ophthalmic function diagnostic procedures | 24.03.05 | Cerebrovascular and spinal vascular disorders NEC |
13.07.05 | Ophthalmic histopathology and imaging procedures | 24.03.06 | Vascular neoplasms |
13.07.06 | Psychiatric investigations | 24.03.07 | Ocular vascular disorders NEC |
13.07.07 | Central nervous system imaging procedures | 24.03.08 | Pulmonary vascular disorders NEC |
13.08.02 | Microbiology and serology tests NEC | 24.04.02 | Non-site specific necrosis and vascular insufficiency NEC |
13.08.03 | Virus identification and serology | 24.04.03 | Peripheral vasoconstriction, necrosis and vascular insufficiency |
13.08.04 | Parasite identification and serology | 24.04.04 | Coronary necrosis and vascular insufficiency |
13.08.05 | Mycobacteria identification and serology | 24.04.05 | Musculoskeletal necrosis and vascular insufficiency |
13.09.01 | Protein analyses NEC | 24.04.06 | Cerebrovascular and spinal necrosis and vascular insufficiency |
13.10.01 | Adrenal medulla tests | 24.04.07 | Hepatic and portal necrosis and vascular insufficiency |
13.10.02 | Gastrointestinal, pancreatic and APUD hormone analyses | 24.04.08 | Gastrointestinal necrosis and vascular insufficiency |
13.10.03 | Pituitary analyses anterior | 24.04.09 | Site specific necrosis and vascular insufficiency NEC |
13.10.05 | Reproductive hormone analyses | 24.04.10 | Retinal necrosis and vascular insufficiency |
13.10.06 | Thyroid analyses | 24.04.11 | Renal necrosis and vascular insufficiency |
13.10.07 | Parathyroid analyses | 24.05.01 | Arterial inflammations |
13.10.09 | Adrenal cortex tests | 24.05.02 | Vasculitides NEC |
13.11.01 | Mineral and electrolyte analyses | 24.05.03 | Phlebitis NEC |
13.11.02 | Water and electrolyte analyses NEC | 24.06.01 | Blood pressure disorders NEC |
13.12.01 | Cholesterol analyses | 24.06.02 | Circulatory collapse and shock |
13.12.02 | Lipoprotein and lipid tests NEC | 24.06.03 | Vascular hypotensive disorders |
13.12.03 | Triglyceride analyses | 24.07.01 | Haemorrhages NEC |
13.13.01 | Renal function analyses | 24.07.02 | Gastrointestinal haemorrhages |
13.13.02 | Urinalysis NEC | 24.07.03 | Reproductive system haemorrhages |
13.13.03 | Urinary tract function analyses NEC | 24.07.04 | Nervous system haemorrhagic disorders |
13.14.01 | Cardiac auscultatory investigations | 24.07.05 | Ocular haemorrhagic disorders |
13.14.02 | Cardiac function diagnostic procedures | 24.07.06 | Bruising, ecchymosis and purpura |
13.14.03 | Vascular tests NEC (incl blood pressure) | 24.08.01 | Accelerated and malignant hypertension |
13.14.04 | Heart rate and pulse investigations | 24.08.02 | Vascular hypertensive disorders NEC |
13.14.05 | ECG investigations | 24.08.03 | Pulmonary hypertensions |
13.14.07 | Cardiac imaging procedures | 24.08.04 | Endocrine and metabolic secondary hypertension |
13.15.01 | Physical examination procedures and organ system status | 24.08.06 | Portal hypertensions |
13.16.01 | Musculoskeletal and soft tissue imaging procedures | 24.08.07 | Pregnancy associated hypertension |
13.17.01 | Therapeutic drug monitoring analyses | 24.09.01 | Lymphoedemas |
13.17.02 | Toxicology laboratory analyses | 24.09.02 | Lymphangiopathies |
13.18.01 | Investigations NEC | 24.10.01 | Varicose veins non-site specific |
13.19.01 | Respiratory and pulmonary function diagnostic procedures | 24.10.02 | Gastrointestinal varicosities and haemorrhoids |
13.19.02 | Respiratory tract and thoracic imaging procedures | 24.11.01 | Vascular injuries NEC |
13.19.03 | Respiratory tract and thoracic histopathology procedures | 24.11.02 | Arterial and aortic injuries |
13.20.01 | Fertility analyses | 25.01.01 | Prophylactic procedures NEC |
13.20.02 | Reproductive organ and breast histopathology procedures | 25.01.02 | Therapeutic procedures NEC |
13.22.01 | Cell marker analyses | 25.01.03 | Anaesthesia and allied procedures |
14.01.01 | Metabolic acidoses (excl diabetic acidoses) | 25.01.04 | Analgesia supportive care |
14.01.02 | Metabolic alkaloses | 25.02.03 | Gastric therapeutic procedures |
14.01.03 | Mixed acid-base disorders | 25.03.01 | Vascular therapeutic procedures NEC |
14.01.04 | Respiratory acidoses | 25.04.01 | Nervous system therapeutic procedures NEC |
14.01.05 | Respiratory alkaloses | 25.05.01 | Dental and gingival therapeutic procedures |
14.02.01 | Food malabsorption and intolerance syndromes (excl sugar intolerance) | 25.05.03 | Nasal therapeutic procedures |
14.02.02 | Sugar intolerance (excl glucose intolerance) | 25.05.05 | Paranasal therapeutic procedures |
14.03.01 | Appetite disorders | 25.05.06 | Tonsillar therapeutic procedures |
14.03.02 | General nutritional disorders NEC | 25.06.01 | Blood and blood product treatment |
14.03.03 | Anorexia nervosa and bulimia | 25.06.03 | Lymphoid tissue therapeutic procedures |
14.04.01 | Calcium metabolism disorders | 25.08.01 | Cardiac therapeutic procedures NEC |
14.04.02 | Magnesium metabolism disorders | 25.09.01 | Biliary tract and gallbladder therapeutic procedures |
14.04.03 | Phosphorus metabolism disorders | 25.09.02 | Hepatic therapeutic procedures |
14.04.04 | Bone metabolism disorders | 25.10.01 | Gynaecological therapeutic procedures NEC |
14.05.01 | Electrolyte imbalance NEC | 25.10.04 | Fertility and fertilisation interventions female |
14.05.02 | Fluid intake increased | 25.12.01 | Skin and subcutaneous tissue therapeutic procedures NEC |
14.05.03 | Potassium imbalance | 25.13.02 | Pleural therapeutic procedures |
14.05.04 | Sodium imbalance | 25.16.01 | Muscle therapeutic procedures |
14.05.05 | Total fluid volume decreased | 26.01.01 | Disability issues |
14.05.06 | Total fluid volume increased | 26.01.02 | Dietary and nutritional issues |
14.05.07 | Antidiuretic hormone related conditions | 26.03.01 | Age related issues |
14.05.08 | Chloride imbalance | 26.05.01 | Pregnancy related circumstances |
14.06.01 | Diabetes mellitus (incl subtypes) | 26.05.02 | Sexuality issues |